Revelation Biosciences, Inc. (REVB) stock
REVBNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as REVBW
$3.88+0.06 (+1.57%)
Close on Nov 17, 2026Market cap $15.46MP/E –Yield –
Revelation Biosciences market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Revelation Biosciences's market cap was $17.04M on Nov 11, 2026, against $95.85M a year earlier. Over the last 5 years it ranged from $1.79M to $102.72B, with a median of $3.37B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $17.04M | -78.8% |
| 2025 | Dec 31, 2025 | $80.30M | -97.0% |
| 2024 | Dec 31, 2024 | $2.66B | -84.3% |
| 2023 | Dec 29, 2023 | $16.95B | -31.5% |
| 2022 | Dec 30, 2022 | $24.76B | -75.9% |
| 2021 | Dec 31, 2021 | $102.72B | -14.4% |
| 2020 | Dec 31, 2020 | $119.94B | – |
See a number that looks wrong?